Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling

Previous work has provided strong evidence for a role of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) and transforming growth factor-β (TGFβ) in inflammation and tumor stroma function, raising the possibility that both signaling pathways are interconnected. We have addressed this hypothesis by microarray analyses of human diploid fibroblasts induced to myofibroblastic differentiation, which revealed a substantial, mostly reverse crosstalk of both pathways and identified distinct classes of genes. A major class encompasses classical PPAR target genes, including ANGPTL4, CPT1A, ADRP and PDK4. These genes are repressed by TGFβ, which is counteracted by PPARβ/δ activation. This is mediated, at least in part, by the TGFβ-induced recruitment of the corepressor SMRT to PPAR response elements, and its release by PPARβ/δ ligands, indicating that TGFβ and PPARβ/δ signals are integrated by chromatin-associated complexes. A second class represents TGFβ-induced genes that are downregulated by PPARβ/δ agonists, exemplified by CD274 and IL6, which is consistent with the anti-inflammatory properties of PPARβ/δ ligands. Finally, cooperative regulation by both ligands was observed for a minor group of genes, including several regulators of cell proliferation. These observations indicate that PPARβ/δ is able to influence the expression of distinct sets of both TGFβ-repressed and TGFβ-activated genes in both directions.

[1]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[2]  Gennaro Ciliberto,et al.  Increased toxin‐induced liver injury and fibrosis in interleukin‐6–deficient mice , 2000, Hepatology.

[3]  Wolfgang Meissner,et al.  Transcriptional Profiling Identifies Functional Interactions of TGFβ and PPARβ/δ Signaling , 2010, The Journal of Biological Chemistry.

[4]  John Turk,et al.  Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver , 2009, Cell.

[5]  D. Williams,et al.  A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. , 1999, Carcinogenesis.

[6]  Pierre Corvol,et al.  Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness , 2006, Proceedings of the National Academy of Sciences.

[7]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[8]  T. Libermann,et al.  Activation of interleukin-6 gene expression through the NF-kappa B transcription factor , 1990, Molecular and cellular biology.

[9]  W. Wahli,et al.  Transcriptional regulation of metabolism. , 2006, Physiological reviews.

[10]  C. Glass,et al.  PPARs and molecular mechanisms of transrepression. , 2007, Biochimica et biophysica acta.

[11]  Karsten Kristiansen,et al.  Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. , 2002 .

[12]  Wolfgang Meissner,et al.  15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist , 2010, Molecular Pharmacology.

[13]  Judith Campisi,et al.  Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network , 2009, Proceedings of the National Academy of Sciences.

[14]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[15]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[16]  Chen,et al.  Is a Ligand for the Adipocyte Determination Factor PPARy , 2004 .

[17]  G. Freeman,et al.  PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.

[18]  V K K Chatterjee,et al.  A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms. , 2005, Endocrinology.

[19]  Sabine Müller-Brüsselbach,et al.  Regulation of Cell Proliferation and Differentiation by PPARβ/δ , 2008, PPAR research.

[20]  Roger R. Gomis,et al.  TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4 , 2008, Cell.

[21]  Philip Hahnfeldt,et al.  Transcriptional Network Governing the Angiogenic Switch in Human Pancreatic Cancer , 2008 .

[22]  R. Evans,et al.  PPAR delta: a dagger in the heart of the metabolic syndrome. , 2006, The Journal of clinical investigation.

[23]  W. Wahli,et al.  Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease. , 2007, Biochimica et biophysica acta.

[24]  L. D. de Windt,et al.  Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts , 2007 .

[25]  B. Spiegelman,et al.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. , 1995, Cell.

[26]  Hyunjung Lim,et al.  Transcriptional Cofactors Exhibit Differential Preference toward Peroxisome Proliferator-Activated Receptors α and δ in Uterine Cells , 2004 .

[27]  Karsten Kristiansen,et al.  Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. , 2002, The Biochemical journal.

[28]  A. Billin,et al.  PPARbeta/delta ligands as modulators of the inflammatory response. , 2008, Current opinion in investigational drugs.

[29]  B. Staels,et al.  Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation , 2000, Inflammation Research.

[30]  Wolfgang Meissner,et al.  Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ‐deficient mice , 2007, The EMBO journal.

[31]  Garret A FitzGerald,et al.  Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. , 2006, American journal of respiratory cell and molecular biology.

[32]  Yanhong Shi,et al.  The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Burdick,et al.  The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  R. Sen,et al.  Faculty Opinions recommendation of Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. , 2010 .

[35]  Jeffrey M Peters,et al.  Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer. , 2009, Biochimica et biophysica acta.

[36]  Giulio Gabbiani,et al.  Modulation of α‐smooth muscle actin expression in fibroblasts by transforming growth factor‐β isoforms: an in vivo and in vitro study , 1996, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[37]  J. Roman,et al.  The Role of PPARs in Lung Fibrosis , 2007, PPAR research.

[38]  Béatrice Desvergne,et al.  From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. , 2006, Progress in lipid research.

[39]  Sabine Müller-Brüsselbach,et al.  A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis , 2008, PPAR research.